These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 23264938)
1. Development of a Stability-Indicating RP-HPLC Method for the Determination of Rupatadine and its Degradation Products in Solid Oral Dosage Form. Trivedi HK; Patel MC Sci Pharm; 2012; 80(4):889-902. PubMed ID: 23264938 [TBL] [Abstract][Full Text] [Related]
2. Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form. Trivedi RK; Patel MC Sci Pharm; 2012; 80(2):353-66. PubMed ID: 22896822 [TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Rosuvastatin and Related Substances in Pharmaceutical Dosage Form. Trivedi HK; Patel MC Sci Pharm; 2012; 80(2):393-406. PubMed ID: 22896825 [TBL] [Abstract][Full Text] [Related]
4. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms. Kumar N; Sangeetha D; Reddy SP J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a simple, sensitive, selective and stability-indicating RP-UPLC method for the quantitative determination of ritonavir and its related compounds. Koppala S; Panigrahi B; Raju SV; Padmaja Reddy K; Ranga Reddy V; Anireddy JS J Chromatogr Sci; 2015; 53(5):662-75. PubMed ID: 25186277 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product. Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation. Kumar N; Sangeetha D Sci Pharm; 2013; 81(3):697-711. PubMed ID: 24106668 [TBL] [Abstract][Full Text] [Related]
8. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms. Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a stability-indicating RP-LC method for famciclovir. Raman NV; Harikrishna KA; Prasad AV; Ratnakar Reddy K; Ramakrishna K J Pharm Biomed Anal; 2009 Dec; 50(5):797-802. PubMed ID: 19632799 [TBL] [Abstract][Full Text] [Related]
10. A validated stability-indicating liquid chromatographic method for determination of degradation impurities and diastereomers in voriconazole tablets. Shaikh KA; Patil AT Sci Pharm; 2012; 80(4):879-88. PubMed ID: 23264937 [TBL] [Abstract][Full Text] [Related]
11. A validated stability-indicating UPLC method for desloratadine and its impurities in pharmaceutical dosage forms. Rao DD; Satyanarayana NV; Malleswara Reddy A; Sait SS; Chakole D; Mukkanti K J Pharm Biomed Anal; 2010 Feb; 51(3):736-42. PubMed ID: 19815361 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of stability indicating the RP-HPLC method for the estimation of related compounds of guaifenesin in pharmaceutical dosage forms. Reddy SP; Babu KS; Kumar N; Sekhar YV Pharm Methods; 2011 Oct; 2(4):229-34. PubMed ID: 23781462 [TBL] [Abstract][Full Text] [Related]
13. Stability-indicating UPLC method for determining related substances and degradants in dronedarone. Pydimarry SP; Cholleti VK; Vangala RR J Chromatogr Sci; 2014 Aug; 52(7):666-75. PubMed ID: 23863770 [TBL] [Abstract][Full Text] [Related]
14. A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms. Rao PV; Kumar MN; Kumar MR Sci Pharm; 2013; 81(1):183-93. PubMed ID: 23641337 [TBL] [Abstract][Full Text] [Related]
15. A Novel, Rapid, and Validated Stability-Indicating UPLC Method for the Estimation of Drotaverine Hydrochloride and Ibuprofen Impurities in Oral Solid Dosage Form. Vijay Kumar R; Rao VU; Anil Kumar N; Venkata Subbaiah B Sci Pharm; 2015; 83(4):567-81. PubMed ID: 26839839 [TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a New Stability-Indicating RP-UPLC Method for the Quantitative Determination of Bromfenac Sodium and Its Impurities in an Ophthalmic Dosage Form. Koppala S; Reddy VR; Anireddy JS J Chromatogr Sci; 2016 Oct; 54(9):1514-1521. PubMed ID: 27270417 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form. Trivedi RK; Patel MC Sci Pharm; 2011; 79(1):97-111. PubMed ID: 21617775 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation. Reddy PS; Sudhakar Babu K; Kumar N J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002 [TBL] [Abstract][Full Text] [Related]
19. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant. Lalitha Devi M; Chandrasekhar KB J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800 [TBL] [Abstract][Full Text] [Related]
20. A novel validated stability indicating high performance liquid chromatographic method for estimation of degradation behavior of ciprofloxacin and tinidazole in solid oral dosage. Vaghela BK; Rao SS J Pharm Bioallied Sci; 2013 Oct; 5(4):298-308. PubMed ID: 24302838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]